Analytical Data
-
Gene name
GYPC
- Application
-
Alternative Names
GYPC;GLPC;GPC;Glycophorin-C
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P04921-1
-
Expression Region
1-57aa
-
AA Sequence
MWSTRSPNST AWPLSLEPDP GMASASTTMH TTTIAEPDPG MSGWPDGRME TSTPTIM
-
Molecular Weight
8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of GYPC recombined proteins has gained significant attention due to their crucial role in various biological processes and their potential applications in biotechnology and medicine. GYPC, a member of the glycophorin family, is known for its involvement in erythrocyte biology and membrane dynamics. Research has revealed the importance of GYPC in maintaining red blood cell stability and functionality, as it serves as a receptor for pathogens and mediates cell interactions. Furthermore, the recombination of GYPC proteins allows for the exploration of their structural and functional properties, enabling scientists to investigate their roles in disease mechanisms, particularly in hemolytic disorders and malaria. By utilizing techniques such as recombinant DNA technology, researchers can produce variants of GYPC that may help in developing diagnostic tools or therapeutic agents. The exploration of GYPC recombined proteins is also pivotal in understanding their potential as targets for vaccine development or in the design of novel drugs. Overall, the investigation of GYPC recombinant proteins holds promise for advancing our knowledge of erythrocyte biology and developing innovative solutions to pressing medical challenges.
